![Frontiers | Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery Frontiers | Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery](https://www.frontiersin.org/files/Articles/741542/fcvm-08-741542-HTML/image_m/fcvm-08-741542-g001.jpg)
Frontiers | Design of a Randomized Placebo-Controlled Trial to Evaluate the Anti-inflammatory and Senolytic Effects of Quercetin in Patients Undergoing Coronary Artery Bypass Graft Surgery
![The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram](https://www.researchgate.net/profile/Ajay-Sharma-120/publication/322288003/figure/fig1/AS:614184249204737@1523444344250/The-structure-of-quercetin-prodrug-under-clinical-trial-phase-1-and-its-synthetic_Q320.jpg)
The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram
![Fisetin, Quercetin & Dasatinib in Clinical Trials | Dr. James Kirkland Interview Series Ep 4 - YouTube Fisetin, Quercetin & Dasatinib in Clinical Trials | Dr. James Kirkland Interview Series Ep 4 - YouTube](https://i.ytimg.com/vi/ca0QC_IZUQQ/hqdefault.jpg)
Fisetin, Quercetin & Dasatinib in Clinical Trials | Dr. James Kirkland Interview Series Ep 4 - YouTube
![Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice | Scientific Reports Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-06448-5/MediaObjects/41598_2022_6448_Fig1_HTML.png)
Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice | Scientific Reports
![Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo- controlled pilot trial on feasibility and tolerability - eBioMedicine Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo- controlled pilot trial on feasibility and tolerability - eBioMedicine](https://www.thelancet.com/cms/attachment/587dba0d-f153-4933-b873-e7da09395329/gr1.jpg)
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo- controlled pilot trial on feasibility and tolerability - eBioMedicine
![Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-13911-w/MediaObjects/41598_2022_13911_Fig2_HTML.png)
Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports
![Effects of quercetin supplementation on endothelial dysfunction biomarkers and depression in post-myocardial infarction patients: A double-blind, placebo-controlled, randomized clinical trial - Clinical Nutrition ESPEN Effects of quercetin supplementation on endothelial dysfunction biomarkers and depression in post-myocardial infarction patients: A double-blind, placebo-controlled, randomized clinical trial - Clinical Nutrition ESPEN](https://clinicalnutritionespen.com/cms/asset/cbf40b99-2d6f-4dce-ba83-9f5b50034d13/gr1.jpg)
Effects of quercetin supplementation on endothelial dysfunction biomarkers and depression in post-myocardial infarction patients: A double-blind, placebo-controlled, randomized clinical trial - Clinical Nutrition ESPEN
![Antioxidants | Free Full-Text | The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature Antioxidants | Free Full-Text | The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature](https://www.mdpi.com/antioxidants/antioxidants-11-00876/article_deploy/html/images/antioxidants-11-00876-g001.png)
Antioxidants | Free Full-Text | The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
![Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design | SpringerLink Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design | SpringerLink](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11357-023-00830-5/MediaObjects/11357_2023_830_Fig5_HTML.png)
Long-term dasatinib plus quercetin effects on aging outcomes and inflammation in nonhuman primates: implications for senolytic clinical trial design | SpringerLink
![Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-022-13911-w/MediaObjects/41598_2022_13911_Fig1_HTML.png)
Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation | Scientific Reports
![PDF] Phase I Clinical Trial of the Flavonoid Quercetin : Pharmacokinetics and Evidence for in Vivo Tyrosine Kinase Inhibition 1 | Semantic Scholar PDF] Phase I Clinical Trial of the Flavonoid Quercetin : Pharmacokinetics and Evidence for in Vivo Tyrosine Kinase Inhibition 1 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c7239b99b745821029f5574f7731e8b00a3b6fd4/3-Table1-1.png)
PDF] Phase I Clinical Trial of the Flavonoid Quercetin : Pharmacokinetics and Evidence for in Vivo Tyrosine Kinase Inhibition 1 | Semantic Scholar
![Tripartite combination of potential pandemic mitigation agents: Vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 Tripartite combination of potential pandemic mitigation agents: Vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/60c74da94c8919a91cad3843/largeThumb/tripartite-combination-of-potential-pandemic-mitigation-agents-vitamin-d-quercetin-and-estradiol-manifest-properties-of-candidate-medicinal-agents-for-mitigation-of-the-severity-of-pandemic-covid-19-defined-by-genomics-guided-tracing-of-sars-co-v-2-target.jpg)
Tripartite combination of potential pandemic mitigation agents: Vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2
![Anti-rheumatic effect of quercetin and recent developments in nano formulation - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08817J Anti-rheumatic effect of quercetin and recent developments in nano formulation - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08817J](https://pubs.rsc.org/image/article/2021/RA/d0ra08817j/d0ra08817j-f3_hi-res.gif)
Anti-rheumatic effect of quercetin and recent developments in nano formulation - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08817J
![Frontiers | Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial Frontiers | Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial](https://www.frontiersin.org/files/Articles/1096853/fphar-13-1096853-HTML/image_m/fphar-13-1096853-g004.jpg)
Frontiers | Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
![Pharmaceuticals | Free Full-Text | Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review Pharmaceuticals | Free Full-Text | Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-01631/article_deploy/html/images/pharmaceuticals-16-01631-g001.png)
Pharmaceuticals | Free Full-Text | Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review
![Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus - ScienceDirect Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0166432822005290-ga1.jpg)
Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus - ScienceDirect
![The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram](https://www.researchgate.net/publication/322288003/figure/fig1/AS:614184249204737@1523444344250/The-structure-of-quercetin-prodrug-under-clinical-trial-phase-1-and-its-synthetic.png)
The structure of quercetin prodrug under clinical trial phase 1 and its... | Download Scientific Diagram
![Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin - Pharma Excipients Improved Oral Absorption of Quercetin from Quercetin Phytosome®, a New Delivery System Based on Food Grade Lecithin - Pharma Excipients](https://www.pharmaexcipients.com/wp-content/uploads/2019/09/Pharmacokinetic-profile-of-quercetin-in-the-clinical-study.png)